Prolonged Expression and Effective Readministration of Erythropoietin Delivered with a Fully Deleted Adenoviral Vector

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Human Gene Therapy

• Publication date

  2000-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/10430340050015473PMID 10779163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus

  2001cited by this paper
• Preexisting Antiadenoviral Immunity Is Not a Barrier to Efficient and Stable Transduction of the Brain, Mediated by Novel High-Capacity Adenovirus Vectors

  2001cited by this paper
• Dystrophin Expression in Muscle Following Gene Transfer with a Fully Deleted ("Gutted") Adenovirus Is Markedly Improved by Trans-Acting Adenoviral Gene Products

  2001cited by this paper
• Efficient and ligand-dependent regulated erythropoietin production by naked dna injection and in vivo electroporation.

  2001cited by this paper
• In Vivo Gene Delivery via Portal Vein and Bile Duct to Individual Lobes of the Rat Liver Using a Polylysine-Based Nonviral DNA Vector in Combination with Chloroquine

  2001cited by this paper
• Long-term correction of urea cycle disorders.

  2001cited by this paper
• Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure

  2000cited by this paper
• Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.

  1999cited by this paper
• Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

  1999cited by this paper
• Adenovirus-mediated regulable target gene expression in vivo.

  1999cited by this paper
• Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector.

  1998cited by this paper
• Erythropoietin for end-stage renal disease.

  1998influential reference
• Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig

  1998cited by this paper
• High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.

  1998cited by this paper
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1-Antitrypsin with Negligible Toxicity

  1998cited by this paper
• Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates

  1998cited by this paper
• The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia

  1998cited by this paper
• High-avidity autoantibodies to cytokines.

  1998cited by this paper
• An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.

  1998cited by this paper
• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

  1998cited by this paper
• Regulation of gene expression in vivo following transduction by two separate rAAV vectors

  1998cited by this paper
• Long-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral Vector

  1997cited by this paper
• Immune Responses to Adenoviral Vectors During Gene Transfer in the Brain

  1997cited by this paper
• Persistence in muscle of an adenoviral vector that lacks all viral genes.

  1997cited by this paper
• Humoral immune response to the capsid components of recombinant adenoviruses: Routes of immunization modulate virus‐induced Ig subclass shifts

  1997cited by this paper
• Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice

  1997cited by this paper
• Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse Lung

  1997cited by this paper
• Erythropoietin: Physiologic and Pharmacologic Aspects

  1997cited by this paper
• A Gene Therapy Approach to Regulated Delivery of Erythropoietin as a Function of Oxygen Tension

  1997cited by this paper
• Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts

  1997influential reference
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996influential reference
• A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

  1996cited by this paper
• Successful expression of human factor IX following repeat administration of adenoviral vector in mice.

  1996cited by this paper
• “Sero-Switch” Adenovirus-Mediated In Vivo Gene Transfer: Circumvention of Anti-Adenovirus Humoral Immune Defenses Against Repeat Adenovirus Vector Administration by Changing the Adenovirus Serotype

  1996cited by this paper
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

  1996cited by this paper
• In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.

  1996cited by this paper
• Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.

  1996cited by this paper
• Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors

  1996influential reference
• Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli

  1996cited by this paper
• Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.

  1996cited by this paper
• Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.

  1995cited by this paper
• Gene therapy for long-term expression of erythropoietin in rats.

  1995cited by this paper
• [2] Techniques for human adenovirus vector construction and characterization

  1995cited by this paper
• Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice

  1995cited by this paper
• Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.

  1995cited by this paper
• Sustained increase in haemoglobin and RBC following long‐term administration of recombinant human erythropoietin to patients with homozygous beta‐thalassaemia

  1995cited by this paper
• Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.

  1995cited by this paper
• Erythropoietin Gene Transfer and Expression in Adult Normal Mice: Use of an Adenovirus Vector

  1994cited by this paper
• Stimulation of erythropoiesis by in vivo gene therapy: physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector.

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.

  1993cited by this paper
• Erythropoietin therapy in renal failure.

  1993influential reference
• GATA‐1 but not SCL induces megakaryocytic differentiation in an early myeloid line.

  1992cited by this paper
• Trial of recombinant human erythropoietin: three patients with thalassemia intermedia [letter]

  1992cited by this paper
• Trial of recombinant human erythropoietin: three patients with thalassemia intermedia.

  1992cited by this paper
• Erythropoietin.

  1991cited by this paper
• Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system.

  1990cited by this paper
• Use of the human elongation factor 1α promoter as a versatile and efficient expression system

  1990cited by this paper
• The Liver: Biology and Pathobiology, 2nd ed

  1989cited by this paper
• Biological characterization of recombinant human erythropoietin.

  1988cited by this paper
• A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication

  1987cited by this paper
• Murine erythropoietin gene: cloning, expression, and human gene homology

  1986cited by this paper
• The Liver: Biology and Pathobiology

  1983cited by this paper

• Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects

  2023cites this paper
• Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers plasma LDL-cholesterol levels in mice

  2012cites this paper
• Cell microencapsulation for therapeutic purposes: towards greater control over biocompatibility

  2012influential citation
• Proprotein Convertase Subtilisin/Kexin Type 9: From the Discovery to the Development of New Therapies for Cardiovascular Diseases

  2012cites this paper
• Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression

  2012cites this paper
• Gene delivery in peritoneal dialysis related peritoneal fibrosis research.

  2012cites this paper
• Construction and evaluation of high-capacity adenoviral vectors for gene therapy applications

  2011cites this paper
• Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design

  2011cites this paper
• Emerging technologies in the delivery of erythropoietin for therapeutics

  2011cites this paper
• Evaluation of hepatitis B virus promoters for sustained transgene expression in mice by bioluminescence imaging.

  2010cites this paper
• Simultaneous inhibition of the constitutively activated nuclear factor κB and of the Interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells

  2008cites this paper
• Careful adjustment of Epo non-viral gene therapy for β-thalassemic anaemia treatment

  2008cites this paper
• Genetic Vaccines and Therapy

  2008cites this paper
• Expression of pIX Gene Induced by Transgene Promoter: Possible Cause of Host Immune Response in First-Generation Adenoviral Vectors

  2007cites this paper
• Novel approaches for immunotherapeutic intervention in Alzheimer's disease.

  2006cites this paper
• Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.

  2006cites this paper
• High expression level of recombinant human erythropoietin in the milk of non-transgenic goats.

  2006cites this paper
• Readministration of helper-dependent adenovirus to mouse lung

  2006cites this paper
• Correlation between retinal nerve fibre layer thickness and optic nerve head size: an optical coherence tomography study

  2005cites this paper
• Aerosol delivery of an enhanced helper‐dependent adenovirus formulation to rabbit lung using an intratracheal catheter

  2005cites this paper
• Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu In vivo Model of Human Multiple Myeloma

  2005cites this paper
• Helper-Dependent Adenoviral Vectors for Gene Therapy

  2005cites this paper
• Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper‐dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin

  2005cites this paper
• Immune responses against tetracycline‐dependent transactivators affect long‐term expression of mouse erythropoietin delivered by a helper‐dependent adenoviral vector

  2005cites this paper
• Helper-dependent adenoviral vectors in experimental gene therapy.

  2005cites this paper
• Gutless adenovirus: last-generation adenovirus for gene therapy

  2005cites this paper
• Adenoviral p53 gene transfer inhibits human Tenon’s capsule fibroblast proliferation

  2005cites this paper
• Regulated and Liver-Specific Tamarin Alpha Interferon Gene Delivery by a Helper-Dependent Adenoviral Vector

  2005cites this paper
• Production and formulation of adenovirus vectors.

  2005cites this paper
• Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper-dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin.

  2005cites this paper
• A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent

  2004cites this paper
• Acute Toxicity After High-Dose Systemic Injection of Helper-Dependent Adenoviral Vectors into Nonhuman Primates

  2004cites this paper
• Flow Cytometric Application of Helper Adenovirus (HAd) Containing GFP Gene Flanked by Two Parallel loxP Sites to Evaluation of 293 Cre‐Complementing Cell Line and Monitoring of HAd in Gutless Ad Production

  2004cites this paper
• Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL

  2004cites this paper
• Delivery of adenoviral DNA to mouse liver.

  2004cites this paper
• Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes.

  2004cites this paper
• Modifying Adenoviral Vectors for Use as Gene-Based Cancer Vaccines

  2004cites this paper
• Retrotransposon-adenovirus hybrid vectors: efficient delivery and stable integration of transgenes via a two-stage mechanism.

  2004cites this paper
• Combination of optison with ultrasound and electroporation increases albumin and thrompoietin transgene expression whilst elongation factor promoter prolongs its duration

  2004cites this paper
• Combination of Optison TM with ultrasound and electroporation increases albumin and thrompoietin transgene expres sion whilst elongation factor promoter prolongs its dura tion

  2004cites this paper
• Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.

  2004cites this paper
• Helper-Dependent Adenoviral Vectors Containing Modified Fiber for Improved Transduction of Developing and Mature Muscle Cells

  2004cites this paper
• Promoters and control elements: designing expression cassettes for gene therapy.

  2004cites this paper
• Sustained Improvement of Muscle Function One Year After Full-Length Dystrophin Gene Transfer into mdx Mice by a Gutted Helper-Dependent Adenoviral Vector

  2004cites this paper
• Genetic Vaccines and Therapy

  2003cites this paper
• Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin.

  2003cites this paper
• Gene Transfer as an Approach to Treating Hemophilia

  2003cites this paper
• A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice

  2003cites this paper
• Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.

  2003cites this paper
• Gene Therapy for Cancer

  2003cites this paper
• In Vivo Ligand-Inducible Regulation of Gene Expression in a Gutless Adenoviral Vector System

  2003cites this paper
• Characterization of cis-acting sequences involved in packaging porcine adenovirus type 3.

  2003cites this paper
• Adenoviral Vectors for Gene Delivery

  2003cites this paper
• Sustaining Transgene Expression in Vivo

  2003cites this paper
• Hyaluronidase Increases Electrogene Transfer Efficiency in Skeletal Muscle

  2002cites this paper
• A DNA-Based Method to Assay Total and Infectious Particle Contents and Helper Virus Contamination in High-Capacity Adenoviral Vector Preparations

  2002cites this paper
• Variables Affecting In Vivo Performance of High-Capacity Adenovirus Vectors

  2002cites this paper
• Improved performance of a fully gutted adenovirus vector containing two full-length dystrophin cDNAs regulated by a strong promoter.

  2002cites this paper
• Adenovirus and Adeno-Associated Virus Vectors

  2002cites this paper
• High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain.

  2002cites this paper
• Helper-dependent adenoviral vectors.

  2002cites this paper
• Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses1

  2002cites this paper
• Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses 1

  2002cites this paper
• Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector

  2002cites this paper
• Superior Tissue-Specific Expression from Tyrosinase and Prostate-Specific Antigen Promoters/Enhancers in Helper-Dependent Compared with First-Generation Adenoviral Vectors

  2002cites this paper
• Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor.

  2002cites this paper
• Cre Levels Limit Packaging Signal Excision Efficiency in the Cre/loxP Helper-Dependent Adenoviral Vector System

  2002cites this paper
• Expression of a New Woodchuck IFN-α Gene by a Helper-Dependent Adenoviral Vector in Woodchuck Hepatitis Virus-Infected Primary Hepatocytes

  2002cites this paper
• Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.

  2002cites this paper
• Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.

  2002cites this paper
• Gutless adenoviral vectors — Promising tools for gene therapy

  2002cites this paper
• A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism.

  2002cites this paper
• Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation.

  2002cites this paper
• High In Vivo Production of a Model Monoclonal Antibody on Adenoviral Gene Transfer

  2002cites this paper
• Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

  2002cites this paper
• Current status and future developments of rhEPO in clinical oncology

  2002cites this paper
• Mögliche neue Indikationen für die Therapie mit Erythropoietin

  2001cites this paper
• Efficient and ligand-dependent regulated erythropoietin production by naked dna injection and in vivo electroporation.

  2001cites this paper
• Preexisting Antiadenoviral Immunity Is Not a Barrier to Efficient and Stable Transduction of the Brain, Mediated by Novel High-Capacity Adenovirus Vectors

  2001cites this paper
• Dystrophin Expression in Muscle Following Gene Transfer with a Fully Deleted ("Gutted") Adenovirus Is Markedly Improved by Trans-Acting Adenoviral Gene Products

  2001cites this paper
• Development of a FLP/frt system for generating helper-dependent adenoviral vectors.

  2001cites this paper
• Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats

  2001cites this paper
• Long-term correction of urea cycle disorders.

  2001cites this paper
• An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus

  2001cites this paper
• Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.

  2001cites this paper
• Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination

  2001cites this paper
• Cre / loxP System in the Orthotopic Gastric Carcinoma Model Cytosine Deaminase / 5-Fluorocytosine Enhanced by the Carcinoembryonic Antigen-specific Suicide Gene Therapy of Updated

  2001cites this paper
• High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.

  2001cites this paper
• [Possible new indications for erythropoietin therapy].

  2001cites this paper
• In Vivo Gene Delivery via Portal Vein and Bile Duct to Individual Lobes of the Rat Liver Using a Polylysine-Based Nonviral DNA Vector in Combination with Chloroquine

  2001cites this paper
• Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.

  2001cites this paper
• High-capacity 'gutless' adenoviral vectors.

  2001cites this paper
• Liver-Specific Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis

  2000cites this paper
• Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure

  2000cites this paper
• Antivector and antitransgene host responses in gene therapy.

  2000cites this paper